Mon, October 4, 2021
Sun, October 3, 2021
Fri, October 1, 2021
Thu, September 30, 2021
Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021
Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021
Mon, September 20, 2021
Fri, September 17, 2021

Andrew Mok Initiated (AMED) at Strong Sell and Held Target at $150 on, Sep 24th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ell-and-held-target-at-150-on-sep-24th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Mok of UBS, Initiated "Amedisys, Inc." (AMED) at Strong Sell and Held Target at $150 on, Sep 24th, 2021.

Andrew has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Taylor of "Cowen & Co." Initiated at Hold and Held Target at $195 on, Friday, September 10th, 2021
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $237 on, Friday, August 6th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


These are the ratings of the 4 analyists that currently disagree with Andrew


  • A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $250 on, Wednesday, August 11th, 2021
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $265 on, Friday, August 6th, 2021

Publication Contributing Sources